Lynch Syndrome Screening
Lynch Syndrome Screening in Dehradun – Genetic Testing & Hereditary Cancer Risk Assessment
Lynch Syndrome, also known as Hereditary Nonpolyposis Colorectal Cancer (HNPCC), is an inherited genetic condition caused by mutations in mismatch repair (MMR) genes such as MLH1, MSH2, MSH6, PMS2, and EPCAM. It significantly increases lifetime risk of several cancers, often at a younger age.
Dr. Yamini Kansal, an AIIMS-trained Gynaecological Oncologist in Dehradun, offers comprehensive Lynch syndrome genetic testing, counseling, and personalized screening protocols to help individuals and families take proactive steps for cancer prevention.
Why Early Lynch Syndrome Screening Matters Early identification allows for intensified surveillance, preventive measures, and better outcomes. People with Lynch Syndrome have up to 80% lifetime risk of colorectal cancer and 40-60% risk of endometrial cancer. Timely genetic testing for Lynch syndrome in Dehradun empowers you with knowledge and customized care.
Cancers Associated with Lynch Syndrome
Lynch syndrome is associated with an increased risk of several types of cancer. These may include:
Colorectal Cancer
People with Lynch syndrome have an increased risk of developing cancer in the colon or rectum. Appropriate surveillance can help detect abnormalities at an earlier stage.
Endometrial Cancer
Endometrial cancer develops in the lining of the uterus. Women with Lynch syndrome may have a higher risk and should discuss individualised gynaecological risk assessment with their specialist.
Ovarian Cancer
Lynch syndrome can also increase the risk of certain ovarian cancers. Personal and family history may help guide further assessment.
Ovarian Cancer
Minimally invasive surgical techniques may be used for selected cervical cancer cases.
Stomach Cancer
Some individuals with Lynch syndrome have an increased risk of stomach cancer. Further evaluation may be considered depending on individual risk factors and clinical guidance.
Other Cancers
Lynch syndrome may also be associated with cancers of the small intestine, urinary tract, biliary tract, pancreas, prostate, brain and certain skin structures.
Who Should Consider Lynch Syndrome Screening?
Genetic risk assessment may be appropriate for individuals with certain personal or family medical histories. You may benefit from discussing Lynch syndrome screening with a specialist if:
Having one of these factors does not automatically mean you have Lynch syndrome. A specialist can assess your history and determine whether further testing is appropriate.
Why Is Lynch Syndrome Screening Important?
Identifying Lynch syndrome can provide important information about inherited cancer risk. It may help:
Genetic testing does not predict with certainty whether someone will develop cancer. It helps assess inherited risk so that appropriate medical decisions can be discussed.
Frequently Asked Questions About Lynch Syndrome Screening
Yes. Lynch syndrome is generally inherited in an autosomal dominant pattern. A person with a disease-associated variant has a 50% chance of passing that variant to each child.
The main genes associated with Lynch syndrome are MLH1, MSH2, MSH6 and PMS2. Certain EPCAM gene deletions can also cause Lynch syndrome.
People with a known family mutation, certain personal cancer histories, early-onset colorectal or endometrial cancer, or a strong family history of associated cancers may benefit from genetic evaluation.
Germline genetic testing can often be performed using a blood or saliva sample. The appropriate sample and test depend on the laboratory and the individual's clinical assessment.
The inherited genetic variant cannot currently be prevented. However, identifying the condition can help guide surveillance and discussions about risk-reducing options based on individual circumstances.